At the same time, using a “Gene Identification by Nonsense-mediated mRNA decay Inhibition (GINI)” strategy, our group identified inactivating SETD2 mutations in 5 out of 10 ccRCC-derived cell lines [91]. Here, SETD2 is linked to nonpapillary renal cell carcinoma.